BCI
ABMD

Brinker Capital Investments’s Abiomed Inc ABMD Stock Holding History

Brinker Capital Investments’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,408
Closed -$2.07M – 1413
2022
Q3 		$2.07M Buy
8,408
+2
+0% +$540 0.04% 450
2022
Q2 		$2.08M Buy
8,406
+310
+4% +$83.7K 0.04% 465
2022
Q1 		$2.68M Sell
8,096
-2,246
-22% -$691K 0.04% 425
2021
Q4 		$3.71M Sell
10,342
-1,070
-9% -$362K 0.05% 351
2021
Q3 		$3.56M Hold
11,412
– – 0.06% 357
2021
Q2 		$3.56M Buy
11,412
+1,086
+11% +$333K 0.05% 406
2021
Q1 		$3.29M Sell
10,326
-9,602
-48% -$3.07M 0.05% 360
2020
Q4 		$6.46M Buy
19,928
+10,118
+103% +$2.8M 0.1% 242
2020
Q3 		$2.72M Buy
+9,810
New +$2.83M 0.05% 377

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Brinker Capital Investments's ABMD Position: Q4 2022 in Review

Brinker Capital Investments sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 8,408 shares — an estimated $2.07M sold.

Brinker Capital Investments first reported a position in ABMD in Q3 2020 and held it in 9 quarters. The position peaked at $6.46M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Brinker Capital Investments reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Brinker Capital Investments sold 8,408 Abiomed Inc shares in Q4 2022, an estimated $2.07M.
  • Brinker Capital Investments first reported a position in Abiomed Inc in Q3 2020 and held it in 9 quarters.
  • Brinker Capital Investments's Abiomed Inc position peaked at $6.46M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Brinker Capital Investments's 13F filing for Q4 2022, filed 6 Feb 2023.